The Guthrie Test, also known as the bacterial inhibition assay, is a newborn screening test used to detect phenylketonuria (PKU) and other metabolic disorders. Developed by Dr. Robert Guthrie in the early 1960s, this test has played a crucial role in early diagnosis and intervention for metabolic diseases, thereby preventing severe health complications.
